Interleukin-19 alleviates experimental autoimmune encephalomyelitis by attenuating antigen-presenting cell activation
H. Horiuchi, B. Parajuli, Y. Ogawa, H. Komiya, S. Jin, K. Takahashi, Y.-T. Azuma, F. Tanaka, A. Suzumura, H. Takeuchi
This study shows IL-19 reduces experimental autoimmune encephalomyelitis by inhibiting macrophage activation and Th17 cell expansion, suggesting potential therapeutic use in multiple sclerosis.
bioRxiv · Jul 15, 2020Immunology